Literature DB >> 18627664

The aging of the HIV epidemic.

Kavita P Bhavan1, Vinay N Kampalath, Edgar Turner Overton.   

Abstract

Since the advent of highly active antiretroviral therapy, life expectancies for persons with HIV infection are similar to those for uninfected people. A growing proportion of HIV-infected individuals are now over the age of 50. We are also seeing an increase in the incidence of HIV infection in older adults. To meet the challenges of the ongoing HIV epidemic, prevention efforts should include a focus on older adults. Also, HIV care providers must address the many comorbidities that are common in the aging population. Additional research will clarify how the processes of aging and HIV infection overlap and interact. This review addresses many of these important considerations.

Entities:  

Mesh:

Year:  2008        PMID: 18627664     DOI: 10.1007/s11904-008-0023-3

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  51 in total

Review 1.  A conceptual framework of frailty: a review.

Authors:  Walter M Bortz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-05       Impact factor: 6.053

2.  American Cancer Society guidelines for breast cancer screening: update 2003.

Authors:  Robert A Smith; Debbie Saslow; Kimberly Andrews Sawyer; Wylie Burke; Mary E Costanza; W Phil Evans; Roger S Foster; Edward Hendrick; Harmon J Eyre; Steven Sener
Journal:  CA Cancer J Clin       Date:  2003 May-Jun       Impact factor: 508.702

3.  Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population.

Authors:  Kristin Mondy; Edgar Turner Overton; Jessica Grubb; Shao Tong; Warren Seyfried; William Powderly; Kevin Yarasheski
Journal:  Clin Infect Dis       Date:  2007-01-22       Impact factor: 9.079

4.  Pretreatment factors associated with 3-year (144-week) virologic and immunologic responses to potent antiretroviral therapy.

Authors:  Ronald J Bosch; Kara Bennett; Ann C Collier; Robert Zackin; Constance A Benson
Journal:  J Acquir Immune Defic Syndr       Date:  2007-03-01       Impact factor: 3.731

5.  Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection.

Authors:  Julia H Arnsten; Ruth Freeman; Andrea A Howard; Michelle Floris-Moore; Yungtai Lo; Robert S Klein
Journal:  AIDS       Date:  2007-03-12       Impact factor: 4.177

6.  "You're awfully old to have this disease": experiences of stigma and ageism in adults 50 years and older living with HIV/AIDS.

Authors:  Charles A Emlet
Journal:  Gerontologist       Date:  2006-12

7.  Social support, distress, and well-being in older men living with HIV infection.

Authors:  Margaret A Chesney; Donald B Chambers; Jonelle M Taylor; Lisa M Johnson
Journal:  J Acquir Immune Defic Syndr       Date:  2003-06-01       Impact factor: 3.731

8.  Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection.

Authors:  Handan Wand; Alexandra Calmy; Dianne L Carey; Katherine Samaras; Andrew Carr; Matthew G Law; David A Cooper; Sean Emery
Journal:  AIDS       Date:  2007-11-30       Impact factor: 4.177

9.  Changes in thymic function with age and during the treatment of HIV infection.

Authors:  D C Douek; R D McFarland; P H Keiser; E A Gage; J M Massey; B F Haynes; M A Polis; A T Haase; M B Feinberg; J L Sullivan; B D Jamieson; J A Zack; L J Picker; R A Koup
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

10.  Class of antiretroviral drugs and the risk of myocardial infarction.

Authors:  Nina Friis-Møller; Peter Reiss; Caroline A Sabin; Rainer Weber; Antonella d'Arminio Monforte; Wafaa El-Sadr; Rodolphe Thiébaut; Stephane De Wit; Ole Kirk; Eric Fontas; Matthew G Law; Andrew Phillips; Jens D Lundgren
Journal:  N Engl J Med       Date:  2007-04-26       Impact factor: 91.245

View more
  30 in total

1.  Age at cancer diagnosis among persons with AIDS in the United States.

Authors:  Meredith S Shiels; Ruth M Pfeiffer; Eric A Engels
Journal:  Ann Intern Med       Date:  2010-10-05       Impact factor: 25.391

2.  HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data.

Authors:  Joel Negin; Robert G Cumming
Journal:  Bull World Health Organ       Date:  2010-08-27       Impact factor: 9.408

3.  Aging with HIV: clinical considerations for an emerging population.

Authors:  David E Vance
Journal:  Am J Nurs       Date:  2010-03       Impact factor: 2.220

4.  The role of catecholamines in HIV neuropathogenesis.

Authors:  R Nolan; P J Gaskill
Journal:  Brain Res       Date:  2018-04-27       Impact factor: 3.252

5.  Non-AIDS-Defining Malignancies in the HIV-Infected Population.

Authors:  Chia-Ching J Wang; Michael J Silverberg; Donald I Abrams
Journal:  Curr Infect Dis Rep       Date:  2014-06       Impact factor: 3.725

Review 6.  Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors:  Stephanie M Matt; Peter J Gaskill
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

7.  HIV and aging: insights from the Asia Pacific HIV Observational Database (APHOD).

Authors:  N Han; S T Wright; C C O'Connor; J Hoy; S Ponnampalavanar; M Grotowski; H X Zhao; A Kamarulzaman
Journal:  HIV Med       Date:  2014-11-18       Impact factor: 3.180

8.  Growing older with HIV/AIDS: new public health challenges.

Authors:  Sean Cahill; Robert Valadéz
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

9.  Age, sex, and nutritional status modify the CD4+ T-cell recovery rate in HIV-tuberculosis co-infected patients on combination antiretroviral therapy.

Authors:  Amara E Ezeamama; Ezekiel Mupere; James Oloya; Leonardo Martinez; Robert Kakaire; Xiaoping Yin; Juliet N Sekandi; Christopher C Whalen
Journal:  Int J Infect Dis       Date:  2015-04-21       Impact factor: 3.623

Review 10.  Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.

Authors:  Peter J Gaskill; Tina M Calderon; Jacqueline S Coley; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-01       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.